Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.445 EUR | +0.83% | +3.71% | -18.00% |
Apr. 25 | Transcript : Nanobiotix S.A., Q4 2023 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Nanobiotix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 19.79M 21.21M | Sales 2025 * | 36.33M 38.95M | Capitalization | 254M 273M |
---|---|---|---|---|---|
Net income 2024 * | -42M -45.03M | Net income 2025 * | -27M -28.95M | EV / Sales 2024 * | 14.1 x |
Net Debt 2024 * | 24.35M 26.1M | Net Debt 2025 * | 28.05M 30.07M | EV / Sales 2025 * | 7.78 x |
P/E ratio 2024 * |
-6.78
x | P/E ratio 2025 * |
-32.4
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.72% |
Latest transcript on Nanobiotix
1 day | +1.11% | ||
1 week | +4.00% | ||
Current month | -4.21% | ||
1 month | -4.88% | ||
3 months | -23.85% | ||
6 months | -5.70% | ||
Current year | -17.77% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Lévy
CEO | Chief Executive Officer | 53 | 03-03-03 |
Bart van Rhijn
DFI | Director of Finance/CFO | 52 | 21-05-31 |
Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CHM | Chairman | 58 | 21-05-24 |
Enno Spillner
BRD | Director/Board Member | 55 | 14-06-17 |
Alain Herrera
BRD | Director/Board Member | 74 | 11-06-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5.445 | +0.83% | 22 348 |
24-04-25 | 5.4 | -2.44% | 26,330 |
24-04-24 | 5.535 | -3.74% | 45,258 |
24-04-23 | 5.75 | +6.88% | 46,597 |
24-04-22 | 5.38 | +2.48% | 37,347 |
Real-time Euronext Paris, April 26, 2024 at 08:38 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.77% | 273M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.98% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- NANO Stock